Clene (CLNN) Competitors

Organigram (NASDAQ:OGI) and Clene (NASDAQ:CLNN) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, community ranking, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Does the media favor OGI or CLNN?

In the previous week, Clene had 3 more articles in the media than Organigram. MarketBeat recorded 5 mentions for Clene and 2 mentions for Organigram. Organigram's average media sentiment score of 1.71 beat Clene's score of -0.10 indicating that Organigram is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Clene	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Do insiders and institutionals hold more shares of OGI or CLNN?

34.6% of Organigram shares are owned by institutional investors. Comparatively, 23.3% of Clene shares are owned by institutional investors. 0.1% of Organigram shares are owned by insiders. Comparatively, 35.3% of Clene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Which has better valuation and earnings, OGI or CLNN?

Organigram has higher revenue and earnings than Clene. Clene is trading at a lower price-to-earnings ratio than Organigram, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram	$194.09M	1.02	-$33.39M	$0.10	14.80
Clene	$350K	106.00	-$49.50M	-$4.04	-1.02

Which has more risk and volatility, OGI or CLNN?

Organigram has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Clene has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500.

Does the MarketBeat Community favor OGI or CLNN?

Organigram received 114 more outperform votes than Clene when rated by MarketBeat users. However, 81.55% of users gave Clene an outperform vote while only 70.71% of users gave Organigram an outperform vote.

Company	Underperform	Outperform
Organigram	Outperform Votes 198 70.71%	Underperform Votes 82 29.29%
Clene	Outperform Votes 84 81.55%	Underperform Votes 19 18.45%

Is OGI or CLNN more profitable?

Organigram has a net margin of -31.69% compared to Clene's net margin of -8,556.77%. Organigram's return on equity of -8.59% beat Clene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram	-31.69%	-8.59%	-6.54%
Clene	-8,556.77%	-1,106.30%	-85.11%

Do analysts recommend OGI or CLNN?

Clene has a consensus target price of $40.00, indicating a potential upside of 868.52%. Given Clene's stronger consensus rating and higher possible upside, analysts clearly believe Clene is more favorable than Organigram.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Clene	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Summary

Organigram beats Clene on 10 of the 19 factors compared between the two stocks.